Caricamento...
Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes
Primary membranous nephropathy is usually caused by antibodies against the podocyte antigen membrane M-type phospholipase A2 receptor (PLA2R). The treatment of membranous nephropathy is not fully satisfactory. The calcineurin inhibitor tacrolimus is used to treat membranous nephropathy, but recurren...
Salvato in:
| Pubblicato in: | J Clin Med |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408934/ https://ncbi.nlm.nih.gov/pubmed/32664235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072178 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|